Literature DB >> 11829702

Nonspecific medication side effects and the nocebo phenomenon.

Arthur J Barsky1, Ralph Saintfort, Malcolm P Rogers, Jonathan F Borus.   

Abstract

Patients taking active medications frequently experience adverse, nonspecific side effects that are not a direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing, and costly, it is rarely studied and poorly understood. The nocebo phenomenon, in which placebos produce adverse side effects, offers some insight into nonspecific side effect reporting. We performed a focused review of the literature, which identified several factors that appear to be associated with the nocebo phenomenon and/or reporting of nonspecific side effects while taking active medication: the patient's expectations of adverse effects at the outset of treatment; a process of conditioning in which the patient learns from prior experiences to associate medication-taking with somatic symptoms; certain psychological characteristics such as anxiety, depression, and the tendency to somatize; and situational and contextual factors. Physicians and other health care personnel can attempt to ameliorate nonspecific side effects to active medications by identifying in advance those patients most at risk for developing them and by using a collaborative relationship with the patient to explain and help the patient to understand and tolerate these bothersome but nonharmful symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829702     DOI: 10.1001/jama.287.5.622

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  173 in total

Review 1.  Is the increasing use of evidence-based pharmacotherapy causing the renaissance of complementary medicine?

Authors:  Samuel Vozeh
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 2.  The use of the placebo effect in clinical medicine--ethical blunder or ethical imperative?

Authors:  Nikola Biller-Andorno
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

Review 3.  Nocebo in headaches: implications for clinical practice and trial design.

Authors:  Dimos D Mitsikostas
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

4.  The emotive impact of medical language.

Authors:  Ana-Maria Vranceanu; Megan Elbon; Margaritha Adams; David Ring
Journal:  Hand (N Y)       Date:  2012-09

5.  The adverse event profile of pregabalin across different disorders: a meta-analysis.

Authors:  Gaetano Zaccara; Piero Perucca; Pier Franco Gangemi
Journal:  Eur J Clin Pharmacol       Date:  2012-01-21       Impact factor: 2.953

6.  Online discussion of drug side effects and discontinuation among breast cancer survivors.

Authors:  Jun J Mao; Annie Chung; Adrian Benton; Shawndra Hill; Lyle Ungar; Charles E Leonard; Sean Hennessy; John H Holmes
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-01-16       Impact factor: 2.890

7.  Short-term side-effects of brain MR examination at 7 T: a single-centre experience.

Authors:  M Cosottini; D Frosini; L Biagi; I Pesaresi; M Costagli; G Tiberi; M Symms; M Tosetti
Journal:  Eur Radiol       Date:  2014-05-10       Impact factor: 5.315

Review 8.  Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management.

Authors:  Kurt Kroenke
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

Review 9.  Placebo: misunderstandings and prejudices.

Authors:  Matthias Breidert; Karl Hofbauer
Journal:  Dtsch Arztebl Int       Date:  2009-11-13       Impact factor: 5.594

10.  Role of young women's depression and stress symptoms in their weekly use and nonuse of contraceptive methods.

Authors:  Kelli Stidham Hall; Caroline Moreau; James Trussell; Jennifer Barber
Journal:  J Adolesc Health       Date:  2013-04-09       Impact factor: 5.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.